A glycoengineered yeast-derived HA1-ferritin nanoparticle vaccine confers protective immunity against H7 avian influenza in chickens

Abstract H7 subtype avian influenza virus is an important zoonotic pathogen threatening the poultry industry and public health. Recombinant subunit vaccines provide a safer alternative to conventional inactivated vaccines, while yeast expression systems offer advantages of low cost, scalability, and engineering flexibility. However, their application in avian influenza vaccine development remains underexplored. In this study, we use the methylotrophic yeast Komagataella phaffii as a low-cost, industrial-scale platform to produce hemagglutinin-1 (HA1) subunits with programmable N -/ O -linked glycosylation. The methanol-utilization-slow (Mut S ) phenotype strain secreted 1.21 g/L HA1, and compared with the standard methanol-utilization-plus (Mut + ) phenotype strain, the N -linked and O -linked glycans were significantly reduced [liquid chromatography–mass spectrometry (LC–MS)/MS glycopeptide profile]. Despite hypoglycosylation, the antigen retained native conformation, binding H7-specific mAb Q74 with a K D of 1.34 × 10 –7 M. SpyTag/SpyCatcher-directed conjugation to ferritin drove quantitative self-assembly into 30 nm virus-like nanoparticles. Formulated with CpG-ODN 1826, the HA1-Mut S -ferritin candidate elicited Hemagglutination inhibition (HI) titers of 6.7 log 2 in specific pathogen-free (SPF) leghorns at 28 days post-immunization (dpi), significantly enhancing HA1-specific IgY responses ( p < 0.0001) while sustaining high-level circulating CD4 + T cells. At 28 dpi, chickens were challenged with 10 6 embryo infectious dose (EID) 50 of H7N9 avian influenza virus; the formulation conferred 100% clinical protection and accelerated viral clearance, matching the performance of conventional inactivated vaccines. Yeast-based processes significantly reduce downstream purification costs and eliminate reliance on chicken embryos, providing a scalable and biosafe platform for rapid avian influenza control.

Authors

Institutions

Publication Details

Journal
Veterinary Research
Published
2026-10-29
DOI
https://doi.org/10.1186/s13567-026-01867-y
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A glycoengineered yeast-derived HA1-ferritin nanoparticle vaccine confers protective immunity against H7 avian influenza in chickens

邵云林, Saixiang Feng, Siqi Xu, Peiqi Liu et al.
1 links
Veterinary Research
Influenza Virus Research Studies
article

A glycoengineered yeast-derived HA1-ferritin nanoparticle vaccine confers protective immunity against H7 avian influenza in chickens

邵云林, Saixiang Feng, Siqi Xu, Peiqi Liu, Bo Su, Han Zheng, Yifeng Huang, Yutong Liu, Ming Liao, Yishan Zhao, Qianyu Li
article en

Abstract

Abstract H7 subtype avian influenza virus is an important zoonotic pathogen threatening the poultry industry and public health. Recombinant subunit vaccines provide a safer alternative to conventional inactivated vaccines, while yeast expression systems offer advantages of low cost, scalability, and engineering flexibility. However, their application in avian influenza vaccine development remains underexplored. In this study, we use the methylotrophic yeast Komagataella phaffii as a low-cost, industrial-scale platform to produce hemagglutinin-1 (HA1) subunits with programmable N -/ O -linked glycosylation. The methanol-utilization-slow (Mut S ) phenotype strain secreted 1.21 g/L HA1, and compared with the standard methanol-utilization-plus (Mut + ) phenotype strain, the N -linked and O -linked glycans were significantly reduced [liquid chromatography–mass spectrometry (LC–MS)/MS glycopeptide profile]. Despite hypoglycosylation, the antigen retained native conformation, binding H7-specific mAb Q74 with a K D of 1.34 × 10 –7 M. SpyTag/SpyCatcher-directed conjugation to ferritin drove quantitative self-assembly into 30 nm virus-like nanoparticles. Formulated with CpG-ODN 1826, the HA1-Mut S -ferritin candidate elicited Hemagglutination inhibition (HI) titers of 6.7 log 2 in specific pathogen-free (SPF) leghorns at 28 days post-immunization (dpi), significantly enhancing HA1-specific IgY responses ( p < 0.0001) while sustaining high-level circulating CD4 + T cells. At 28 dpi, chickens were challenged with 10 6 embryo infectious dose (EID) 50 of H7N9 avian influenza virus; the formulation conferred 100% clinical protection and accelerated viral clearance, matching the performance of conventional inactivated vaccines. Yeast-based processes significantly reduce downstream purification costs and eliminate reliance on chicken embryos, providing a scalable and biosafe platform for rapid avian influenza control.

Veterinary ResearchVol. 57(1)
South China Agricultural University (CN), Ministry of Agriculture and Rural Affairs (CN), Zhongkai University of Agriculture and Engineering (CN)
National Key Research and Development Program of China
Zero hunger, Good health and well-being
Openalex Percentile: Top 12%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon